The Australian TGA Advice on Equivalence of Herbal Extracts in Complementary Medicines (Australian Government. Department of Health, 2011) identifies the following as a number of the components that impact the phytoequivalence of extracts: starting material good quality, solvent alternatives, and manufacturing procedures like time and temperature.